Atomico leads $22m series-A in Kheiron

Exor Seeds, Greycroft, Hoxton Ventures and Connect Ventures also participated.

Atomico is currently investing from its Atomico IV fund, which closed on $765m.

The fresh capital will go towards conducting large-scale clinical trials globally.

Previous funding
A number of investors including Walking Ventures, Samos Investments, Isomer Capital and Connect Ventures contributed a total of £10,000 to the company in 2016.

Greycroft invested an undisclosed amount in the company in 2017.

Connect Ventures, 7percent Ventures and Newgen Venture Partners also invested an undisclosed amount in 2017.

Kheiron received a grant of €71,400 from the EU Executive Agency for SMEs in January 2019.

Company
Founded in 2016, Kheiron offers software that looks at areas of interest in full-field digital mammography images from breast cancer screenings. Based in London, the company employs 44 people, according to LinkedIn.

People
Atomico – Irina Haivas (principal).
Kheiron Medical Technologies – Peter Kecskemethy (CEO); Tobias Rijken (chief technology officer).

• Tweet  
• Facebook  
• LinkedIn  
• Google plus  
• Send to  

• Topics
• Early-stage
• UK / Ireland
• Technology
• United Kingdom
• Atomico
• Connect Ventures
• Venture